If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £111.95m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Transaction in Own Shares

5 Mar 2026 07:00

RNS Number : 3804V
Mercia Asset Management PLC
05 March 2026
 

RNS

5 March 2026

 

Mercia Asset Management PLC

 

("Mercia", the "Company" or the "Group")

 

Transaction in Own Shares

 

 

Mercia Asset Management PLC (AIM: MERC), the regionally focused, private capital asset manager with c.£2.0billion of assets under management, announces that it has made the following purchases of Ordinary shares in the capital of the Company ("Ordinary Shares") on the London Stock Exchange, pursuant to the Share Buyback Programme announced on 1 July 2025.

 

Date of purchase

4 March 2026

Number of Ordinary Shares purchased (aggregated volume):

40,000

Highest price paid per Ordinary Share (pence):

27.70

Lowest price paid per Ordinary Share (pence):

27.70

Volume weighted average price paid per Ordinary Share (pence):

27.70

Venue where Ordinary Shares are traded

London Stock Exchange (AIM)

The Company intends to cancel the shares. Following the purchase, the number of Ordinary Shares in issue and admitted to trading on AIM will be 425,705,672 (excluding treasury shares), and the Company is holding 11,746,458 Ordinary Shares in treasury.

 

This figure of 425,705,672 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The Company will make further announcements in due course following the completion of any further purchases pursuant to the Share Buyback Programme.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Canaccord Genuity Limited on behalf of the Company.

 

 

Individual transactions:

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Trading venue

40,000

27.70

08:32:08

London Stock Exchange (AIM)

 

- Ends -

 

For further information, please contact:

 

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk +44 (0)330 223 1430

 

Canaccord Genuity Limited (NOMAD and Joint Broker)

Simon Bridges, Andrew Potts, Harry Rees +44 (0)20 7523 8000

 

Singer Capital Markets (Joint Broker)

Charles Leigh-Pemberton +44 (0)20 7496 3000

 

FTI Consulting

Tom Blackwell, Thomas Lodge +44 (0)20 3727 1051

mercia@fticonsulting.com

 

About Mercia Asset Management PLC

Mercia is a private capital asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, debt, private equity and proprietary capital: the Group's 'Complete Connected Capital'.

 

The Group has a strong UK footprint through its 11 regional offices, extensive local adviser and personal networks, and university partnerships, providing it with access to high-quality deal flow.

 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZLFBQXLFBBZ
Date   Source Headline
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board
11th Oct 20167:00 amRNSDigital & Digital Entertainment Portfolio Update
5th Oct 20167:00 amRNSCapital Markets Event
27th Sep 20167:00 amRNSInvestment into innovative healthcare - Medherant
19th Sep 201610:36 amRNSResult of AGM
26th Aug 20167:00 amRNSDirector/PDMR Shareholdings
29th Jul 20167:00 amRNSPublication of Annual Report
28th Jul 20167:00 amRNSGrant Options & PDMR Dealings
26th Jul 20168:30 amRNSRe. Admission to AIM of Concepta PLC
21st Jul 20167:00 amRNSnDreams launches The Assembly for Oculus RIFT
7th Jul 20167:00 amRNSAcquisition, Placing & Open Offer, Change of Name
7th Jul 20167:00 amRNSFundraising & AIM Admission of Direct Investment
30th Jun 20167:00 amRNSPreliminary Results
20th Jun 20167:00 amRNSFour New University Partnerships
1st Jun 20167:00 amRNSNotice of Preliminary Results
26th May 20167:00 amRNSBoard Changes
20th May 20167:00 amRNSMercia's nDreams signs Google VR app deal
9th May 20167:00 amRNSFirst Direct Investment via Enterprise Ventures
17th Mar 20163:30 pmRNSNotification of Major Interest in Shares
17th Mar 20167:00 amRNSNew Direct Investment
10th Mar 20167:02 amRNSAcquisition of Enterprise Ventures

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.